Australia's iNova, Juno PC deal sparks probe into market for phentermine weight-loss drugs
The proposed acquisition of Australian pharmaceutical joint venture Juno PC by iNova Pharmaceuticals has prompted the country’s competition regulator to focus its review of the deal on the market for prescription...To view the full article, register now.
Already a subscriber? Click here to view full article